HK1103355A1 - Novel tellurium compounds and their use as immunomodulators - Google Patents
Novel tellurium compounds and their use as immunomodulatorsInfo
- Publication number
- HK1103355A1 HK1103355A1 HK07111672.5A HK07111672A HK1103355A1 HK 1103355 A1 HK1103355 A1 HK 1103355A1 HK 07111672 A HK07111672 A HK 07111672A HK 1103355 A1 HK1103355 A1 HK 1103355A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- immunomodulators
- tellurium compounds
- novel
- novel tellurium
- compounds
- Prior art date
Links
- 239000002955 immunomodulating agent Substances 0.000 title 1
- 229940121354 immunomodulator Drugs 0.000 title 1
- 150000003498 tellurium compounds Chemical class 0.000 title 1
- 102100035904 Caspase-1 Human genes 0.000 abstract 2
- 108090000426 Caspase-1 Proteins 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 229910052714 tellurium Inorganic materials 0.000 abstract 1
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C395/00—Compounds containing tellurium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F11/00—Compounds containing elements of Groups 6 or 16 of the Periodic Table
- C07F11/005—Compounds containing elements of Groups 6 or 16 of the Periodic Table compounds without a metal-carbon linkage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61066004P | 2004-09-17 | 2004-09-17 | |
PCT/IL2005/000989 WO2006030437A2 (fr) | 2004-09-17 | 2005-09-15 | Nouveaux compose a base de tellure et leurs utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1103355A1 true HK1103355A1 (en) | 2007-12-21 |
Family
ID=35985262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07111672.5A HK1103355A1 (en) | 2004-09-17 | 2007-10-30 | Novel tellurium compounds and their use as immunomodulators |
Country Status (11)
Country | Link |
---|---|
US (5) | US20090269418A1 (fr) |
EP (3) | EP1791535B1 (fr) |
JP (1) | JP2008513439A (fr) |
AT (1) | ATE402709T1 (fr) |
AU (1) | AU2005283719A1 (fr) |
CA (3) | CA2580643C (fr) |
DE (1) | DE602005008622D1 (fr) |
ES (2) | ES2312012T3 (fr) |
HK (1) | HK1103355A1 (fr) |
PT (1) | PT1796660T (fr) |
WO (3) | WO2006030439A2 (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2550459C (fr) | 2003-12-18 | 2009-12-15 | Biomas, Ltd. | Derives du tellure pour la prevention et le traitement des processus neurodegeneratifs |
PT1715785E (pt) * | 2004-01-22 | 2014-06-24 | Biomas Ltd | Métodos terapêuticos e composições farmacêuticas para tratar verrugas com compostos de telúrio |
WO2006030440A2 (fr) * | 2004-09-17 | 2006-03-23 | Biomas Ltd. | Utilisation de composes a base de tellure comme adjuvants |
EP1791535B1 (fr) | 2004-09-17 | 2008-07-30 | BioMAS Ltd. | Nouveaux compose a base de tellure et leurs utilisations |
EP1841597A4 (fr) | 2005-01-11 | 2010-01-27 | Jemtex Ink Jet Printing Ltd | Imprimante a jet d'encre et procede de commande |
US8080237B2 (en) * | 2005-09-15 | 2011-12-20 | Benjamin Sredni | Use of tellurium compounds for protection from ultra-violet radiation |
EP1862166A1 (fr) * | 2006-06-01 | 2007-12-05 | Yolanda Rodemer | Utilisation de l'allopurinol pour le traitement de l'erythrodysesthesie palmo-plantaire |
EP2035006B1 (fr) * | 2006-06-01 | 2010-02-17 | Nobera Pharma, S.L. | Utilisation d'allopurinol pour le traitement de l'érythrodysesthésie palmaire et plantaire |
EP2076274A4 (fr) | 2006-09-11 | 2010-08-04 | Biomas Ltd | Formulations topiques de composés contenant du tellure |
WO2009066301A2 (fr) * | 2007-11-23 | 2009-05-28 | Biomas Ltd. | Procédés et compositions de traitement de poxvirus au moyen de composés contenant du tellure |
SI2826371T1 (sl) * | 2007-11-23 | 2019-09-30 | Feramda Ltd. | Metode in sestavki za inhibiranje integrinov z uporabo spojin, ki vsebujejo telur |
EP2385758A4 (fr) * | 2009-01-08 | 2013-01-23 | Biomas Ltd | Composés contenant du tellure pour agir sur le système reproducteur féminin après une chimiothérapie et/ou une radiothérapie |
US20110275709A1 (en) * | 2009-01-08 | 2011-11-10 | Biomas Ltd. | Tellurium-containing compounds for affecting male's fertility following chemotherapy and/or radiotherapy |
EP2246057A1 (fr) | 2009-04-29 | 2010-11-03 | Nobera Pharma, S.L. | Utilisation d'allopurinol pour le traitement d'une cutiréaction sur les mains et sur les pieds |
WO2010146547A1 (fr) * | 2009-06-16 | 2010-12-23 | Biomas Ltd. | Composés contenant du tellure destinés à faciliter une transplantation |
CA2774999A1 (fr) | 2009-09-30 | 2011-04-07 | President And Fellows Of Harvard College | Procedes de modulation de l'autophagie par la modulation de produits geniques renforcant l'autophagie |
WO2012065065A1 (fr) * | 2010-11-12 | 2012-05-18 | Follica, Inc. | Procédés et compositions pour moduler la pousse de cheveux, la cicatrisation de plaie et la révision de cicatrice |
WO2012078649A1 (fr) | 2010-12-06 | 2012-06-14 | Follica, Inc. | Procédés destinés à traiter la calvitie et à favoriser la croissance des cheveux |
US11318163B2 (en) | 2015-02-18 | 2022-05-03 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
US11596652B2 (en) | 2015-02-18 | 2023-03-07 | Enlivex Therapeutics R&D Ltd | Early apoptotic cells for use in treating sepsis |
US11000548B2 (en) | 2015-02-18 | 2021-05-11 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
US11304976B2 (en) | 2015-02-18 | 2022-04-19 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
US11497767B2 (en) | 2015-02-18 | 2022-11-15 | Enlivex Therapeutics R&D Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
IL284985B2 (en) | 2015-02-18 | 2023-03-01 | Enlivex Therapeutics R& D Ltd | Combined immunotherapy and cytokine control therapy for cancer treatment |
KR20170138534A (ko) | 2015-04-21 | 2017-12-15 | 엔리벡스 테라퓨틱스 리미티드 | 치료적 혼주된 혈액 아폽토시스 세포 제제 및 이의 용도 |
EP3416661A4 (fr) | 2016-02-18 | 2020-03-04 | Enlivex Therapeutics Ltd. | Association d'une immunothérapie et d'une thérapie de contrôle des cytokines pour le traitement du cancer |
US11427538B2 (en) * | 2017-04-28 | 2022-08-30 | Kyoto University | Organic tellurium compound, method for producing same, living radical polymerization initiator, method for producing vinyl polymer, and vinyl polymer |
EP3644989A4 (fr) | 2017-06-30 | 2021-07-14 | The Regents of the University of California | Compositions et procédés de modulation de la pousse des cheveux |
AU2018339064A1 (en) * | 2017-09-29 | 2020-02-27 | The Regents Of The University Of California | Compositions and methods for modulating hair growth |
JP2021042161A (ja) * | 2019-09-11 | 2021-03-18 | 国立大学法人東海国立大学機構 | 脱毛剤、脱毛モデル動物及び白髪モデル動物 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3369550A (en) | 1967-02-17 | 1968-02-20 | Thomas A. Armao | Cryogenic clamps |
GB1427415A (en) | 1973-09-21 | 1976-03-10 | Armao T A | Cryosurgical instruments |
US4139619A (en) * | 1976-05-24 | 1979-02-13 | The Upjohn Company | 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth |
US4761490A (en) | 1985-03-15 | 1988-08-02 | Bar-Ilan University | Organic derivatives of tellurium and selenium and their use to stimulate cytokine production |
US4962207A (en) * | 1985-09-30 | 1990-10-09 | Bar-Ilan University | Organic derivatives of tellurium and selenium |
US5102908A (en) * | 1985-03-15 | 1992-04-07 | Michael Albeck | Method of treating Acquired Immunedeficiency Syndrome (AIDS) using organic tellurium and selenium derivatives |
US4764461A (en) * | 1985-09-30 | 1988-08-16 | Bar-Ilan University | Tellurium and selenium compounds for the induction of in vivo and in vitro production of cytokines |
US4752614A (en) | 1985-09-30 | 1988-06-21 | Bar-Ilan University | Pharmaceutical compositions of tellerium and selenium compounds for the induction of in vivo and in vitro production of cytokines |
US5093135A (en) * | 1985-09-30 | 1992-03-03 | Michael Albeck | Compounds for the induction of in vivo and in vitro production of cytokines |
US4929739A (en) | 1988-03-24 | 1990-05-29 | Bar-Ilan University | Complexes of tellurium and selenium derivatives |
US5271925A (en) | 1990-03-09 | 1993-12-21 | Benjamin Sredni | Method for protecting against the effects of radiation which is based on the administration of a selenium or tellurium based compound |
DE4007473A1 (de) | 1990-03-09 | 1991-09-12 | Tomsk G Med I | Kryoskalpell |
US5213899A (en) * | 1990-12-17 | 1993-05-25 | General Electric Company | Room temperature vulcanizable silicone compositions |
US5262149A (en) | 1992-08-13 | 1993-11-16 | Benjamin Sredni | Method of treating or preventing alopecia |
CZ283875B6 (cs) | 1994-09-01 | 1998-06-17 | The Upjohn Company | Kosolventní parenterální formulace tirilazadu |
US5576347A (en) | 1994-11-14 | 1996-11-19 | Sredni; Benjamin | Method of treating gastric ulcers |
AU699442B2 (en) * | 1994-12-15 | 1998-12-03 | Baker Norton Pharmaceuticals, Inc. | Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound |
US5654328A (en) * | 1994-12-15 | 1997-08-05 | Sredni; Benjamin | Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds |
SI1064298T1 (sl) * | 1998-03-19 | 2009-02-28 | Vertex Pharma | Inhibitorji kaspaz |
US6428534B1 (en) | 1999-02-24 | 2002-08-06 | Cryovascular Systems, Inc. | Cryogenic angioplasty catheter |
ATE363465T1 (de) * | 1999-04-09 | 2007-06-15 | Cytovia Inc | Caspase inhibitoren und ihre verwendung |
AU2001265008A1 (en) * | 2000-05-23 | 2001-12-03 | Vertex Pharmaceuticals Incorporated | Caspase inhibitors and uses thereof |
IL152845A0 (en) * | 2000-06-07 | 2003-06-24 | Vertex Pharma | Fused heterocyclic compounds and pharmaceutical compositions containing the same |
WO2001098325A1 (fr) | 2000-06-19 | 2001-12-27 | University Of Southern California | Procedes de traitement et de prevention de l'alopecie |
US6747008B1 (en) * | 2000-06-19 | 2004-06-08 | University Of Southern California | Methods for treating and preventing alopecia |
AP2003002811A0 (en) * | 2000-11-21 | 2003-06-30 | Vertex Pharma | Imidazole and benzimidazole caspase inhibitors and uses thereof |
US20030148970A1 (en) | 2001-01-12 | 2003-08-07 | Besterman Jeffrey M. | Methods for specifically inhibiting histone deacetylase-4 |
WO2002094263A2 (fr) * | 2001-05-23 | 2002-11-28 | Vertex Pharmaceuticals Incorporated | Inhibiteurs de caspase et leurs utilisations |
US6472381B1 (en) | 2001-10-12 | 2002-10-29 | Biomas Inc. | Method of treating psoriasis |
IL146694A (en) * | 2001-11-22 | 2010-12-30 | Biomas Ltd | Use of an aqueous solution containing a biologically active complex of tellurium dioxide for manufacturing a medicament |
EP1539701A1 (fr) * | 2002-06-28 | 2005-06-15 | Vertex Pharmaceuticals Incorporated | Inhibiteurs de caspases et leurs utilisations |
CN100366612C (zh) * | 2002-12-20 | 2008-02-06 | 沃泰克斯药物股份有限公司 | 4-氧代-3-(1-氧代-1h-异喹啉-2-基乙酰氨基)-戊酸酯和酰胺衍生物及其作为天冬氨酸特异性半胱氨酸蛋白酶抑制剂的用途 |
CA2550459C (fr) * | 2003-12-18 | 2009-12-15 | Biomas, Ltd. | Derives du tellure pour la prevention et le traitement des processus neurodegeneratifs |
CA2580399C (fr) * | 2004-09-15 | 2015-07-07 | Itamar Medical Ltd. | Procede et appareil permettant de mesurer de facon non invasive des parametres physiologiques, notamment le flux sanguin et la capacite veineuse |
WO2006030440A2 (fr) | 2004-09-17 | 2006-03-23 | Biomas Ltd. | Utilisation de composes a base de tellure comme adjuvants |
EP1791535B1 (fr) * | 2004-09-17 | 2008-07-30 | BioMAS Ltd. | Nouveaux compose a base de tellure et leurs utilisations |
-
2005
- 2005-09-15 EP EP05779419A patent/EP1791535B1/fr not_active Not-in-force
- 2005-09-15 AT AT05779419T patent/ATE402709T1/de not_active IP Right Cessation
- 2005-09-15 CA CA2580643A patent/CA2580643C/fr not_active Expired - Fee Related
- 2005-09-15 DE DE602005008622T patent/DE602005008622D1/de active Active
- 2005-09-15 EP EP05784166A patent/EP1802292A4/fr not_active Withdrawn
- 2005-09-15 ES ES05779419T patent/ES2312012T3/es active Active
- 2005-09-15 WO PCT/IL2005/000991 patent/WO2006030439A2/fr active Application Filing
- 2005-09-15 AU AU2005283719A patent/AU2005283719A1/en not_active Abandoned
- 2005-09-15 WO PCT/IL2005/000989 patent/WO2006030437A2/fr active IP Right Grant
- 2005-09-15 CA CA002580804A patent/CA2580804A1/fr not_active Abandoned
- 2005-09-15 CA CA2580642A patent/CA2580642C/fr not_active Expired - Fee Related
- 2005-09-15 PT PT57796393T patent/PT1796660T/pt unknown
- 2005-09-15 US US11/662,743 patent/US20090269418A1/en not_active Abandoned
- 2005-09-15 EP EP05779639.3A patent/EP1796660B1/fr not_active Not-in-force
- 2005-09-15 US US11/663,031 patent/US7652065B2/en not_active Expired - Fee Related
- 2005-09-15 US US11/663,032 patent/US7709524B2/en not_active Expired - Fee Related
- 2005-09-15 WO PCT/IL2005/000990 patent/WO2006030438A2/fr active Application Filing
- 2005-09-15 ES ES05779639.3T patent/ES2614113T3/es active Active
- 2005-09-15 JP JP2007531953A patent/JP2008513439A/ja active Pending
-
2007
- 2007-10-30 HK HK07111672.5A patent/HK1103355A1/xx not_active IP Right Cessation
-
2009
- 2009-12-02 US US12/629,071 patent/US20100081623A1/en not_active Abandoned
-
2010
- 2010-03-22 US US12/728,362 patent/US8623908B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1103355A1 (en) | Novel tellurium compounds and their use as immunomodulators | |
MXPA05008246A (es) | Inhibidores de histona desacetilasa. | |
SG166770A1 (en) | Use of adipose tissue-derived stromal stem cells in treating fistula | |
MX2022001199A (es) | Compuestos de urea, amida y heteroarilo sustituido para la inhibicion de cbl-b. | |
MX2009006542A (es) | Inhibidores de histona desacetilasa y sus profarmacos. | |
WO2005117846A3 (fr) | Traitement de maladies a l'aide d'inhibiteurs de l'ice | |
SG10201805844QA (en) | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | |
MXPA04002397A (es) | Inhibidores de histona deacetilasa. | |
EP1841463A4 (fr) | Méthodes et compositions destinées à traiter, inhiber et inverser des discopathies intervertébrales | |
AU2001248701A1 (en) | Inhibitors of histone deacetylase | |
TWI367886B (en) | Proteasome inhibitors and methods of using the same | |
MX2010006154A (es) | Tratamiento del cancer con combinaciones de inhibidores de la topoisomerasa e inhibidores de la poli-adp-ribosa-polimerasa. | |
WO2006133403A3 (fr) | Inhibiteurs de l'activite serine protease et leur utilisation dans des procedes et compositions pour le traitement du rejet du greffon et la promotion de la survie du greffon | |
WO2007111948A3 (fr) | Inhibiteurs de prényltransférases protéiques | |
WO2012037155A3 (fr) | Inhibiteurs des tyrosines kinases | |
IL173722A0 (en) | Proteasome inhibitors and methods of using the same | |
HK1089153A1 (en) | Proteasome inhibitors and methods of using the same | |
IL178968A0 (en) | Novel pyridazinone derivatives as inhibitors of cdk2 | |
MX2009002960A (es) | Inhibidores de serina hidrolasa. | |
WO2008090417A3 (fr) | Inhibition de nf-kb | |
TW200745059A (en) | Sulfonyl-substituted bicyclic compounds as modulators of PPAR | |
MY162518A (en) | Proteasome inhibitors and methods of using the same | |
WO2006104751A3 (fr) | Methodes et compositions pour moduler une transcription genique mediee par rho | |
ATE435246T1 (de) | Wässrige behandlungszusammensetzungen und polymere zur verwendung darin | |
UA27355U (en) | Method for purification of natural and after-purification of potable water |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210915 |